GALECTO BIOTECH ApS: Financial statements 2017
CVR: 34878366
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR -2,112,610 and a net result of EUR -2,741,160 compared with EUR -1,842,834 the year before. Equity in the 2017 report amounted to EUR -9,187,931. The company had 4 employees in the financial year.
- Gross Profit
- EUR -2,112,610
- Profit/Loss
- EUR -2,741,160
- Equity
- EUR -9,187,931
- Total Assets
- EUR 1,454,859
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -2.1 mio. EUR | -2.7 mio. EUR | -9.2 mio. EUR | 4 |
| 2016 | - | -1.3 mio. EUR | -1.8 mio. EUR | -6.5 mio. EUR | - |
| 2015 | - | 865 t. EUR | -504 t. EUR | -4.6 mio. EUR | - |
| 2014 | - | -15 mio. | -12 mio. | -30.6 mio. | - |
| 2013 | - | -15 mio. | -17.1 mio. | -18.6 mio. | - |
Keep an eye on GALECTO BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
GALECTO BIOTECH ApS has published its annual report for 2016. Gross profit came to DKK -1,338,209, and the net result was DKK -1,842,834.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.